Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Nitric oxide signaling in pregnancy and preeclampsia.

Sutton EF, Gemmel M, Powers RW.

Nitric Oxide. 2020 Feb 1;95:55-62. doi: 10.1016/j.niox.2019.11.006. Epub 2019 Dec 15. Review.

PMID:
31852621
2.

In Reply.

Hauspurg A, Sutton EF, Caritis SN, Powers RW, Catov JM.

Obstet Gynecol. 2019 Jan;133(1):190-191. doi: 10.1097/AOG.0000000000003046. No abstract available.

PMID:
30575663
3.

Maternal Outcomes Associated With Lower Range Stage 1 Hypertension.

Sutton EF, Hauspurg A, Caritis SN, Powers RW, Catov JM.

Obstet Gynecol. 2018 Oct;132(4):843-849. doi: 10.1097/AOG.0000000000002870.

4.

Extracellular matrix regenerative graft attenuates the negative impact of polypropylene prolapse mesh on vagina in rhesus macaque.

Liang R, Knight K, Barone W, Powers RW, Nolfi A, Palcsey S, Abramowitch S, Moalli PA.

Am J Obstet Gynecol. 2017 Feb;216(2):153.e1-153.e9. doi: 10.1016/j.ajog.2016.09.073. Epub 2016 Sep 8.

5.

Low Soluble Syndecan-1 Precedes Preeclampsia.

Gandley RE, Althouse A, Jeyabalan A, Bregand-White JM, McGonigal S, Myerski AC, Gallaher M, Powers RW, Hubel CA.

PLoS One. 2016 Jun 14;11(6):e0157608. doi: 10.1371/journal.pone.0157608. eCollection 2016.

6.

Urinary cortisol and depression in early pregnancy: role of adiposity and race.

Luiza JW, Gallaher MJ, Powers RW.

BMC Pregnancy Childbirth. 2015 Feb 13;15:30. doi: 10.1186/s12884-015-0466-7.

7.

Activation of adenosine A2B receptor impairs properties of trophoblast cells and involves mitogen-activated protein (MAP) kinase signaling.

Darashchonak N, Sarisin A, Kleppa MJ, Powers RW, von Versen-Höynck F.

Placenta. 2014 Sep;35(9):763-71. doi: 10.1016/j.placenta.2014.06.369. Epub 2014 Jun 26.

PMID:
25002363
8.

Arginine and asymmetric dimethylarginine in pregnant women with major depression.

Raw A, Gallaher M, Powers RW.

Psychosom Med. 2014 Jul-Aug;76(6):430-6. doi: 10.1097/PSY.0000000000000077.

9.

Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women.

Founds SA, Ren D, Roberts JM, Jeyabalan A, Powers RW.

Reprod Sci. 2015 Apr;22(4):402-9. doi: 10.1177/1933719114529372. Epub 2014 Apr 3.

10.

Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy.

Weissgerber TL, Rajakumar A, Myerski AC, Edmunds LR, Powers RW, Roberts JM, Gandley RE, Hubel CA.

J Clin Endocrinol Metab. 2014 Mar;99(3):978-87. doi: 10.1210/jc.2013-3277. Epub 2013 Dec 11.

11.

Redefining preeclampsia using placenta-derived biomarkers.

Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers RW, Charnock-Jones DS, Redman CW.

Hypertension. 2013 May;61(5):932-42. doi: 10.1161/HYPERTENSIONAHA.111.00250. Epub 2013 Mar 4. Review. No abstract available.

PMID:
23460278
12.

Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis).

Julian CG, Vargas E, Gonzales M, Dávila RD, Ladenburger A, Reardon L, Schoo C, Powers RW, Lee-Chiong T, Moore LG.

Respir Physiol Neurobiol. 2013 Apr 1;186(2):188-96. doi: 10.1016/j.resp.2013.01.016. Epub 2013 Feb 4.

13.

An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype.

Holguin F, Comhair SA, Hazen SL, Powers RW, Khatri SS, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Fitzpatrick AM, Gaston B, Israel E, Jarjour NN, Moore WC, Peters SP, Teague WG, Chung KF, Erzurum SC, Wenzel SE.

Am J Respir Crit Care Med. 2013 Jan 15;187(2):153-9. doi: 10.1164/rccm.201207-1270OC. Epub 2012 Nov 29.

14.

Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia?

Powers RW, Roberts JM, Plymire DA, Pucci D, Datwyler SA, Laird DM, Sogin DC, Jeyabalan A, Hubel CA, Gandley RE.

Hypertension. 2012 Jul;60(1):239-46. doi: 10.1161/HYPERTENSIONAHA.112.191213. Epub 2012 May 29.

15.

Haptoglobin phenotype, angiogenic factors, and preeclampsia risk.

Weissgerber TL, Roberts JM, Jeyabalan A, Powers RW, Lee M, Datwyler SA, Gandley RE.

Am J Obstet Gynecol. 2012 Apr;206(4):358.e10-8. doi: 10.1016/j.ajog.2012.01.009. Epub 2012 Jan 13.

16.

An exploratory factor analysis of nutritional biomarkers associated with major depression in pregnancy.

Bodnar LM, Wisner KL, Luther JF, Powers RW, Evans RW, Gallaher MJ, Newby PK.

Public Health Nutr. 2012 Jun;15(6):1078-86. doi: 10.1017/S1368980011002904. Epub 2011 Dec 8.

17.

Cardiovascular system during the postpartum state in women with a history of preeclampsia.

Evans CS, Gooch L, Flotta D, Lykins D, Powers RW, Landsittel D, Roberts JM, Shroff SG.

Hypertension. 2011 Jul;58(1):57-62. doi: 10.1161/HYPERTENSIONAHA.111.173278. Epub 2011 May 23.

18.

The Role of Obesity in Preeclampsia.

Roberts JM, Bodnar LM, Patrick TE, Powers RW.

Pregnancy Hypertens. 2011 Jan 1;1(1):6-16. doi: 10.1016/j.preghy.2010.10.013.

19.

Caffeine and insulin resistance in pregnancy.

Laughon SK, Powers RW, Roberts JM, Parana S, Catov J.

Am J Perinatol. 2011 Aug;28(7):571-8. doi: 10.1055/s-0031-1274511. Epub 2011 Mar 4.

20.

First trimester uric acid and adverse pregnancy outcomes.

Laughon SK, Catov J, Powers RW, Roberts JM, Gandley RE.

Am J Hypertens. 2011 Apr;24(4):489-95. doi: 10.1038/ajh.2010.262. Epub 2011 Jan 20.

21.

Effect of smoking on circulating angiogenic factors in high risk pregnancies.

Jeyabalan A, Powers RW, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 12;5(10):e13270. doi: 10.1371/journal.pone.0013270.

22.

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 11;5(10):e13263. doi: 10.1371/journal.pone.0013263.

23.

Does C-reactive protein predict recurrent preeclampsia?

Gammill HS, Powers RW, Clifton RG, Van Dorsten JP, Klebanoff MA, Lindheimer MD, Sibai B, Landon MB, Miodovnik M, Dombrowski M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD.

Hypertens Pregnancy. 2010;29(4):399-409. doi: 10.3109/10641950903214633.

24.

Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia.

Luppi P, Powers RW, Verma V, Edmunds L, Plymire D, Hubel CA.

Reprod Sci. 2010 Jul;17(7):643-52. doi: 10.1177/1933719110366164. Epub 2010 Apr 1.

25.

Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor.

von Versen-Höynck F, Rajakumar A, Bainbridge SA, Gallaher MJ, Roberts JM, Powers RW.

Placenta. 2009 May;30(5):434-42. doi: 10.1016/j.placenta.2009.02.004. Epub 2009 Mar 19.

26.

Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia.

von Versen-Hoeynck FM, Hubel CA, Gallaher MJ, Gammill HS, Powers RW.

Am J Hypertens. 2009 Jun;22(6):687-92. doi: 10.1038/ajh.2009.54. Epub 2009 Mar 12.

27.

Leptin affects system A amino acid transport activity in the human placenta: evidence for STAT3 dependent mechanisms.

von Versen-Höynck F, Rajakumar A, Parrott MS, Powers RW.

Placenta. 2009 Apr;30(4):361-7. doi: 10.1016/j.placenta.2009.01.004. Epub 2009 Feb 8.

28.

Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women.

Rajakumar A, Powers RW, Hubel CA, Shibata E, von Versen-Höynck F, Plymire D, Jeyabalan A.

Placenta. 2009 Jan;30(1):25-34. doi: 10.1016/j.placenta.2008.10.006. Epub 2008 Nov 17.

29.

Vascular endothelial growth factor and breast cancer risk.

Reeves KW, Ness RB, Stone RA, Weissfeld JL, Vogel VG, Powers RW, Modugno F, Cauley JA.

Cancer Causes Control. 2009 Apr;20(3):375-86. doi: 10.1007/s10552-008-9252-4. Epub 2008 Nov 6.

30.

Placental system A amino acid transport is reduced in pregnancies with small for gestational age (SGA) infants but not in preeclampsia with SGA infants.

Shibata E, Hubel CA, Powers RW, von Versen-Hoeynck F, Gammill H, Rajakumar A, Roberts JM.

Placenta. 2008 Oct;29(10):879-82. doi: 10.1016/j.placenta.2008.07.001. Epub 2008 Aug 20.

31.

Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia.

Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB.

Am J Hypertens. 2008 Aug;21(8):943-7. doi: 10.1038/ajh.2008.219. Epub 2008 Jun 19.

32.

Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women.

Jenkins LD, Powers RW, Cooper M, Gallaher MJ, Markovic N, Ferrell R, Ness RB, Roberts JM.

Reprod Sci. 2008 Sep;15(7):696-701. doi: 10.1177/1933719108316984. Epub 2008 Jun 18.

33.

C-reactive protein is elevated 30 years after eclamptic pregnancy.

Hubel CA, Powers RW, Snaedal S, Gammill HS, Ness RB, Roberts JM, Arngrímsson R.

Hypertension. 2008 Jun;51(6):1499-505. doi: 10.1161/HYPERTENSIONAHA.108.109934. Epub 2008 Apr 14.

34.

A comparison of circulating TNF-alpha in obese and lean women with and without preeclampsia.

Founds SA, Powers RW, Patrick TE, Ren D, Harger GF, Markovic N, Roberts JM.

Hypertens Pregnancy. 2008;27(1):39-48. doi: 10.1080/10641950701825838.

35.

Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome.

Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, Roberts JM.

Reprod Sci. 2008 Apr;15(4):374-381. doi: 10.1177/1933719107311780. Epub 2008 Jan 9.

36.

Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants.

Speer PD, Powers RW, Frank MP, Harger G, Markovic N, Roberts JM.

Am J Obstet Gynecol. 2008 Jan;198(1):112.e1-7. doi: 10.1016/j.ajog.2007.05.052.

37.

Maternal leptin across pregnancy in women with small-for-gestational-age infants.

Catov JM, Patrick TE, Powers RW, Ness RB, Harger G, Roberts JM.

Am J Obstet Gynecol. 2007 Jun;196(6):558.e1-8.

PMID:
17547894
38.

Maternal vitamin D deficiency increases the risk of preeclampsia.

Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM.

J Clin Endocrinol Metab. 2007 Sep;92(9):3517-22. Epub 2007 May 29.

39.

Sir2 and calorie restriction in yeast: a skeptical perspective.

Kaeberlein M, Powers RW 3rd.

Ageing Res Rev. 2007 Aug;6(2):128-40. Epub 2007 Apr 19. Review.

PMID:
17512264
40.

Maternal leptin concentrations are similar in African Americans and Caucasians in normal pregnancy, preeclampsia and small-for-gestational-age infants.

Jenkins LD, Powers RW, Adotey M, Gallaher MJ, Markovic N, Ness RB, Roberts JM.

Hypertens Pregnancy. 2007;26(1):101-9.

PMID:
17454222
41.

Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids.

Frank MP, Powers RW.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):646-9. Epub 2007 Jan 13.

42.

High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates.

Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM.

J Nutr. 2007 Feb;137(2):447-52.

43.

Maternal-fetal metabolism in normal pregnancy and preeclampsia.

von Versen-Hoeynck FM, Powers RW.

Front Biosci. 2007 Jan 1;12:2457-70. Review.

PMID:
17127255
44.

Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia.

Laivuori H, Gallaher MJ, Collura L, Crombleholme WR, Markovic N, Rajakumar A, Hubel CA, Roberts JM, Powers RW.

Mol Hum Reprod. 2006 Sep;12(9):551-6. Epub 2006 Jul 26.

PMID:
16870954
45.

Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation.

Shibata E, Powers RW, Rajakumar A, von Versen-Höynck F, Gallaher MJ, Lykins DL, Roberts JM, Hubel CA.

Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1009-16. Epub 2006 Jun 20.

46.

Pituitary removal in adult mice increases life span.

Powers RW 3rd, Harrison DE, Flurkey K.

Mech Ageing Dev. 2006 Aug;127(8):658-9. Epub 2006 Apr 27.

PMID:
16643985
47.

Extension of chronological life span in yeast by decreased TOR pathway signaling.

Powers RW 3rd, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S.

Genes Dev. 2006 Jan 15;20(2):174-84.

48.

Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery.

Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP, Daftary AR, Roberts JM.

Am J Obstet Gynecol. 2006 Jan;194(1):160.

PMID:
16389026
49.

Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients.

Kaeberlein M, Powers RW 3rd, Steffen KK, Westman EA, Hu D, Dang N, Kerr EO, Kirkland KT, Fields S, Kennedy BK.

Science. 2005 Nov 18;310(5751):1193-6.

50.

Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension.

Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW.

Hypertension. 2005 Dec;46(6):1263-9. Epub 2005 Oct 24.

PMID:
16246973

Supplemental Content

Loading ...
Support Center